160 related articles for article (PubMed ID: 2575783)
1. The multidrug resistance gene in renal cell carcinoma.
Klein EA
Semin Urol; 1989 Nov; 7(4):207-14. PubMed ID: 2575783
[No Abstract] [Full Text] [Related]
2. Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma.
Chapman AE; Goldstein LJ
Semin Oncol; 1995 Feb; 22(1):17-28. PubMed ID: 7855615
[No Abstract] [Full Text] [Related]
3. Multidrug resistance.
Moscow JA; Cowan KH
Cancer Chemother Biol Response Modif; 1991; 12():91-109. PubMed ID: 1681846
[No Abstract] [Full Text] [Related]
4. [GP-170 glycoprotein and resistance to chemotherapy].
Lazarowski AJ
Medicina (B Aires); 1991; 51(3):279-80. PubMed ID: 1687986
[No Abstract] [Full Text] [Related]
5. Targeted for destruction: the molecular basis for development of novel therapeutic strategies in renal cell cancer.
Srinivasan R; Linehan WM
J Clin Oncol; 2005 Jan; 23(3):410-2. PubMed ID: 15572728
[No Abstract] [Full Text] [Related]
6. The multidrug resistance phenotype in human cancer.
Cordon-Cardo C; O'Brien JP
Important Adv Oncol; 1991; ():19-38. PubMed ID: 1678363
[No Abstract] [Full Text] [Related]
7. [Perspectives on modulation of chemoresistance of malignant diseases].
Allerödder HP; Ukena D; Sybrecht GW
Pneumologie; 1993 Sep; 47(9):513-7. PubMed ID: 7901849
[No Abstract] [Full Text] [Related]
8. Multidrug resistance.
Moscow JA; Cowan KH
Cancer Chemother Biol Response Modif; 1990; 11():97-114. PubMed ID: 1977437
[No Abstract] [Full Text] [Related]
9. Prognostic implications of polymorphisms and interleukin-2 therapy for renal cell carcinoma.
Gardner TA; Logan T
J Urol; 2009 Aug; 182(2):425-6. PubMed ID: 19524946
[No Abstract] [Full Text] [Related]
10. Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788.
Efferth T; Dunn TA; Berlion M; Langenbahn H; Pommerenke EW; Volm M
Anticancer Res; 1993; 13(4):905-8. PubMed ID: 8102519
[TBL] [Abstract][Full Text] [Related]
11. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
González-Manzano R
Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
[No Abstract] [Full Text] [Related]
12. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
Pasman PC; Schouten HC
Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
[TBL] [Abstract][Full Text] [Related]
13. [Glycoprotein in multidrug-resistant malignancies--clinical implications].
Ellis A; Lishner M; Manor J; Ravid M
Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806
[No Abstract] [Full Text] [Related]
14. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene.
Mickisch GH; Merlino GT; Aiken PM; Gottesman MM; Pastan I
J Urol; 1991 Aug; 146(2):447-53. PubMed ID: 1677434
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic events associated with renal cell carninoma and its implication to treatment by molecular target therapy.
Kishida T; Yao M; Uemura H; Ohlmann C; Tomita Y; Bukowski RM; Naito S
Int J Urol; 2010 Mar; 17(3):198-205. PubMed ID: 20409215
[No Abstract] [Full Text] [Related]
16. Multiple drug resistance in cancer therapy.
Schneider E; Cowan KH
Med J Aust; 1994 Mar; 160(6):371-3. PubMed ID: 7907772
[No Abstract] [Full Text] [Related]
17. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
[TBL] [Abstract][Full Text] [Related]
18. [Multidrug resistance in hematological malignancies: prognostic significance and the effect of resistance-modulating drugs].
Sonneveld P; te Boekhorst PA
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):508-12. PubMed ID: 7908127
[No Abstract] [Full Text] [Related]
19. Resistance to the tubulin-binding agents in renal cell carcinoma: no mutations in the class I beta-tubulin gene but changes in tubulin isotype protein expression.
Ferguson RE; Taylor C; Stanley A; Butler E; Joyce A; Harnden P; Patel PM; Selby PJ; Banks RE
Clin Cancer Res; 2005 May; 11(9):3439-45. PubMed ID: 15867246
[TBL] [Abstract][Full Text] [Related]
20. Advances in chemotherapy for renal cell carcinoma.
Huben RP
Semin Urol; 1992 Feb; 10(1):16-22. PubMed ID: 1565899
[No Abstract] [Full Text] [Related]
[Next] [New Search]